Long-term Cardiovascular and All-Cause Mortality following Elective Infrarenal Repair of the Abdominal Aortic Aneurysm: A Systematic Review and Meta-analysis.

IF 1.5 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE
Journal of Endovascular Therapy Pub Date : 2026-06-01 Epub Date: 2024-12-30 DOI:10.1177/15266028241304627
Samira E M van Knippenberg, Cecilia Fenelli, Susan van Dieren, Ronak Delewi, Ron Balm, Kak Khee Yeung
{"title":"Long-term Cardiovascular and All-Cause Mortality following Elective Infrarenal Repair of the Abdominal Aortic Aneurysm: A Systematic Review and Meta-analysis.","authors":"Samira E M van Knippenberg, Cecilia Fenelli, Susan van Dieren, Ronak Delewi, Ron Balm, Kak Khee Yeung","doi":"10.1177/15266028241304627","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patients with abdominal aortic aneurysms (AAAs) have poor survival rates after aneurysm repair compared with the general population, potentially due to increased cardiovascular risk. This systematic review and meta-analysis aimed to assess the long-term incidence of all-cause and cardiovascular mortality after elective, infrarenal AAA repair.</p><p><strong>Method: </strong>The Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines were followed (PROSPERO ID: CRD42022344547). Studies published in PubMed, Web of Science, and COCHRANE databases between January 2013 and May 2023 with a mean follow-up time of ≥5 years were included. A weighted linear regression analysis was performed to determine the annual incidence of all-cause and cardiovascular mortality five years after AAA repair. A random effects model calculated the overall incidence rates per 1000 person-years (PY). Endovascular aneurysm repair (EVAR) and open surgical repair (OSR) were compared.</p><p><strong>Results: </strong>Nineteen studies with 84 212 patients (mean follow-up: 68.9 [±13.3] months) were included. Common preoperative cardiovascular comorbidities included hypertension (74.4%), dyslipidemia (43.6%), and coronary artery disease (27.6%). At five years, the mean all-cause mortality was 29.78%, and cardiovascular mortality was 11.98%, with an annual increase of 6.59% and 2.46%, respectively (R<sup>2</sup>=0.809, p<0.001 and R<sup>2</sup>=0.824, p<0.001). The random effects model showed an all-cause mortality rate of 62.99 events (95% CI=57.53-68.96; <i>I</i><sup>2</sup>=93%) per 1000 PY and a cardiovascular mortality rate of 24.19 events per 1000 PY (95% CI=21.69-26.98; <i>I</i><sup>2</sup>=66%). Patients undergoing an EVAR had a significant higher incidence of all-cause and cardiovascular mortality than patients undergoing an OSR (B-coefficient 4.10 and 2.39, both p<0.001, respectively).</p><p><strong>Conclusion: </strong>The long-term all-cause and cardiovascular mortality remain high following elective, infrarenal AAA repair. These findings highlight a much needed optimization and emphasis of cardiovascular risk management, to minimize the long-term incidence of cardiovascular mortality in patients with AAA following surgical intervention.Clinical ImpactThis study evaluated the long-term outcomes of cardiovascular and all-cause mortality rates following elective repair of the infrarenal abdominal aortic aneurysm. The results of this systematic review and meta-analysis emphasizes the suboptimal cardiovascular risk profile observed in this patient population. Futhermore, it highlights the importance of optimization and emphasis of cardiovascular risk management, including in the long-term after surgical intervention.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":"33 3","pages":"1115-1125"},"PeriodicalIF":1.5000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Endovascular Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15266028241304627","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/30 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Patients with abdominal aortic aneurysms (AAAs) have poor survival rates after aneurysm repair compared with the general population, potentially due to increased cardiovascular risk. This systematic review and meta-analysis aimed to assess the long-term incidence of all-cause and cardiovascular mortality after elective, infrarenal AAA repair.

Method: The Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines were followed (PROSPERO ID: CRD42022344547). Studies published in PubMed, Web of Science, and COCHRANE databases between January 2013 and May 2023 with a mean follow-up time of ≥5 years were included. A weighted linear regression analysis was performed to determine the annual incidence of all-cause and cardiovascular mortality five years after AAA repair. A random effects model calculated the overall incidence rates per 1000 person-years (PY). Endovascular aneurysm repair (EVAR) and open surgical repair (OSR) were compared.

Results: Nineteen studies with 84 212 patients (mean follow-up: 68.9 [±13.3] months) were included. Common preoperative cardiovascular comorbidities included hypertension (74.4%), dyslipidemia (43.6%), and coronary artery disease (27.6%). At five years, the mean all-cause mortality was 29.78%, and cardiovascular mortality was 11.98%, with an annual increase of 6.59% and 2.46%, respectively (R2=0.809, p<0.001 and R2=0.824, p<0.001). The random effects model showed an all-cause mortality rate of 62.99 events (95% CI=57.53-68.96; I2=93%) per 1000 PY and a cardiovascular mortality rate of 24.19 events per 1000 PY (95% CI=21.69-26.98; I2=66%). Patients undergoing an EVAR had a significant higher incidence of all-cause and cardiovascular mortality than patients undergoing an OSR (B-coefficient 4.10 and 2.39, both p<0.001, respectively).

Conclusion: The long-term all-cause and cardiovascular mortality remain high following elective, infrarenal AAA repair. These findings highlight a much needed optimization and emphasis of cardiovascular risk management, to minimize the long-term incidence of cardiovascular mortality in patients with AAA following surgical intervention.Clinical ImpactThis study evaluated the long-term outcomes of cardiovascular and all-cause mortality rates following elective repair of the infrarenal abdominal aortic aneurysm. The results of this systematic review and meta-analysis emphasizes the suboptimal cardiovascular risk profile observed in this patient population. Futhermore, it highlights the importance of optimization and emphasis of cardiovascular risk management, including in the long-term after surgical intervention.

选择性肾下腹主动脉瘤修复术后的长期心血管和全因死亡率:一项系统回顾和荟萃分析。
背景:与一般人群相比,腹主动脉瘤(AAAs)患者在动脉瘤修复后的生存率较低,可能是由于心血管风险增加。本系统综述和荟萃分析旨在评估选择性肾下AAA修复后全因死亡率和心血管死亡率的长期发生率。方法:遵循系统评价和荟萃分析(PRISMA)指南的首选报告项目(PROSPERO ID: CRD42022344547)。纳入2013年1月至2023年5月期间在PubMed、Web of Science和COCHRANE数据库中发表的平均随访时间≥5年的研究。采用加权线性回归分析确定AAA修复后5年全因死亡率和心血管死亡率的年发生率。随机效应模型计算了每1000人年(PY)的总发病率。血管内动脉瘤修复(EVAR)与开放手术修复(OSR)进行比较。结果:纳入19项研究,共84 212例患者(平均随访68.9[±13.3]个月)。常见的术前心血管合并症包括高血压(74.4%)、血脂异常(43.6%)和冠状动脉疾病(27.6%)。5年时,平均每1000 PY全因死亡率为29.78%,心血管死亡率为11.98%,年增长率分别为6.59%和2.46% (R2=0.809, p2=0.824, pI2=93%),心血管死亡率为24.19件/ 1000 PY (95% CI=21.69 ~ 26.98; I2=66%)。接受EVAR的患者的全因死亡率和心血管死亡率明显高于接受OSR的患者(b系数分别为4.10和2.39)。结论:选择性肝下AAA修复术后的长期全因死亡率和心血管死亡率仍然很高。这些发现强调了对心血管风险管理的优化和重视,以尽量减少手术干预后AAA患者心血管死亡率的长期发生率。临床影响:本研究评估了选择性修复肾下腹主动脉瘤后心血管和全因死亡率的长期结局。本系统综述和荟萃分析的结果强调了在该患者人群中观察到的次优心血管风险概况。此外,它强调了优化和强调心血管风险管理的重要性,包括在手术干预后的长期。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.30
自引率
15.40%
发文量
203
审稿时长
6-12 weeks
期刊介绍: The Journal of Endovascular Therapy (formerly the Journal of Endovascular Surgery) was established in 1994 as a forum for all physicians, scientists, and allied healthcare professionals who are engaged or interested in peripheral endovascular techniques and technology. An official publication of the International Society of Endovascular Specialists (ISEVS), the Journal of Endovascular Therapy publishes peer-reviewed articles of interest to clinicians and researchers in the field of peripheral endovascular interventions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书